197 related articles for article (PubMed ID: 12056702)
1. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
[TBL] [Abstract][Full Text] [Related]
2. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
4. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
6. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Jahnke K; Korfel A; Komm J; Bechrakis NE; Stein H; Thiel E; Coupland SE
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):663-9. PubMed ID: 16228920
[TBL] [Abstract][Full Text] [Related]
7. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
[TBL] [Abstract][Full Text] [Related]
8. Combined modality therapy for primary CNS lymphoma.
DeAngelis LM; Yahalom J; Thaler HT; Kher U
J Clin Oncol; 1992 Apr; 10(4):635-43. PubMed ID: 1548527
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
10. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.
Ferreri AJ; Reni M; Villa E
Ann Oncol; 2000 Aug; 11(8):927-37. PubMed ID: 11038028
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.
Kreher S; Strehlow F; Martus P; Roth P; Hertenstein B; Röth A; Birnbaum T; Griesinger F; Rauch M; Kanz L; Thiel E; Weller M; Korfel A
Ann Hematol; 2015 Mar; 94(3):409-14. PubMed ID: 25217230
[TBL] [Abstract][Full Text] [Related]
13. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
Grimm SA; Pulido JS; Jahnke K; Schiff D; Hall AJ; Shenkier TN; Siegal T; Doolittle ND; Batchelor T; Herrlinger U; Neuwelt EA; Laperriere N; Chamberlain MC; Blay JY; Ferreri AJ; Omuro AM; Thiel E; Abrey LE
Ann Oncol; 2007 Nov; 18(11):1851-5. PubMed ID: 17804469
[TBL] [Abstract][Full Text] [Related]
14. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
[TBL] [Abstract][Full Text] [Related]
16. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
18. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
[TBL] [Abstract][Full Text] [Related]
19. Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
Thomas-Joulié A; Houillier C; Antoni D; Créhange G; Jouglar E; Colin P; Benchalal M; Lang P; Alfonsi M; Hamidou H; Coutte A; Ahrweiller F; Dadoun N; Pointreau Y; Ammarguellat H; Bernier-Chastagner V; Belkacemi Y; Vieillot S; Hoang-Xuan K; Soussain C; Jacob J; Feuvret L
Acta Oncol; 2023 Jun; 62(6):648-656. PubMed ID: 37338525
[TBL] [Abstract][Full Text] [Related]
20. Intraocular lymphoma: report of three cases and review of the literature.
Trudeau M; Shepherd FA; Blackstein ME; Gospodarowicz M; Fitzpatrick P; Moffatt KP
Am J Clin Oncol; 1988 Apr; 11(2):126-30. PubMed ID: 3282423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
